Strate Labs

Strate Labs is a Canadian research-chemical vendor that operates parallel storefronts under stratelabs.ca and a .is domain, and that markets itself as having "10+ years" of operation. The product catalog spans peptides (BPC-157, GHK-Cu, HCG, Cagrilintide, Semaglutide, and Retatrutide sold under the in-house "Semathin" brand) as well as SARMs, oral capsules, and topical formulations — a broader format mix than most peptide-only Canadian vendors. Pricing is denominated in CAD and free shipping is offered on Canadian orders over $250. The site publishes batch- and lot-coded Certificates of Analysis and uses tamper-evident vial seals. The most consequential thing a prospective buyer should know about Strate Labs is its active legal exposure: Strate Labs was found in default in an Eli Lilly civil action in May 2024 related to compounds covered by Lilly's IP (most relevantly the GLP-1 family), and has been named in a U.S. International Trade Commission investigation involving trademark and false-advertising claims. The use of multiple domains (including a .is fallback) is consistent with grey-market vendors that anticipate registrar takedowns. Independent reviewer ratings hover around 3.9 / 5 across consumer review sites, and the primary payment channel is Interac e-Transfer, which offers limited consumer-side reversibility compared with card payments.